SCHEMBL6206528

SCHEMBL6206528

O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CC(CNC(=O)c1ccccc1)OC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB7A P51149 5/20 0.55
MAPT P10636 4/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
ESR2 Q92731 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTPN1 P18031 8/20 0.48
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
NPC1 O15118 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PTPN2 P17706 3/20 0.47
PTPRC P08575 2/20 0.47
PTPRB P23467 2/20 0.47
PTPRE P23469 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315022 0.93 RAB7A (0.51) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315632 0.92 RAB7A (0.47) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315979 0.91 MEN1 (0.54) RAB7AMAPTRAB9ALMNAPOLB
SCHEMBL6316963 0.90 PTPN1 (0.47) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315826 0.89 RAB7A (0.46) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315982 0.89 SMN1; SMN2 (0.49) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315228 0.89 PTPN1 (0.43) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6321243 0.88 ALDH1A1 (0.53) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6315812 0.88 PTPN1 (0.46) RAB7AMAPTRAB9ASMN1; SMN2HPGD
SCHEMBL6322130 0.88 RAB7A (0.47) RAB7AMAPTRAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214325-B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK AS (DK) 2005-11-09 EP claimed
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US claimed
US-6410586-B1 ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS NOVO NORDISK A/S (DK) 2002-06-25 US claimed
EP-1214325-B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK AS (DK) 2005-11-09 EP disclosed
US-6951878-B2 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2005-10-04 US disclosed
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US disclosed
US-6410586-B1 ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS NOVO NORDISK A/S (DK) 2002-06-25 US disclosed
US-6262044-B1 CONTAINING AN AMIDE-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE RING NOVO NORDISK A/S (DK) 2001-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRA RAB7A 3644/4885MAPT 475/4885RAB9A 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.